FarmaMondo Partners with Cordex to Expand Zemcelpro
LUGANO, Switzerland & MONTREAL, Canada, July 16, 2026 FarmaMondo Group has entered an exclusive commercial partnership with Cordex Biologics...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
LUGANO, Switzerland & MONTREAL, Canada, July 16, 2026 FarmaMondo Group has entered an exclusive commercial partnership with Cordex Biologics...
MELBOURNE, Australia, July 17, 2026 Dimerix Limited has secured an initial AU$10 million non-dilutive loan facility to strengthen its...
RAHWAY, N.J., July 16, 2026 Merck has achieved a significant milestone in cardiovascular medicine with the U.S. Food and...
INDIANAPOLIS and NEW YORK, July 16, 2026 Eli Lilly and Company has announced a definitive agreement to acquire AtaiBeckley...
BRIDGEWATER, N.J., July 16, 2026 Insmed Incorporated has announced positive 12-month results from the ongoing open-label extension (OLE) study...
WATERTOWN, Mass., July 16, 2026 Diagonal Therapeutics has reached a significant milestone in rare disease drug development by announcing...
SAN MATEO, Calif., July 7, 2026 Helix has announced a multi-year strategic agreement with AstraZeneca to accelerate genomic research,...
ALAMEDA, Calif., July 7, 2026 Vivani Medical, Inc. has entered into a new strategic agreement with Novo Nordisk to...
MEQUON, Wis., July 7, 2026 Vector Science & Therapeutics Corp. has entered into a landmark exclusive licensing and cGMP...
ROSWELL, Ga., DUBLIN, Ireland & HAMILTON, Bermuda, July 7, 2026 Saol Therapeutics has announced the resubmission of its New...
